The vascular S1P gradient-cellular sources and biological significance
- PMID: 18674637
- PMCID: PMC2636563
- DOI: 10.1016/j.bbalip.2008.07.003
The vascular S1P gradient-cellular sources and biological significance
Abstract
Sphingosine 1-phosphate (S1P), a product of sphingomyelin metabolism, is enriched in the circulatory system whereas it is estimated to be much lower in interstitial fluids of tissues. This concentration gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes. S1P levels in blood and lymph are estimated to be in the muM range. In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking. During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions. Thus, the presence of the vascular S1P gradient is thought to contribute to physiological and pathological conditions. From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.
Similar articles
-
Vascular biology: the role of sphingosine 1-phosphate in both the resting state and inflammation.J Cell Mol Med. 2010 Sep;14(9):2211-22. doi: 10.1111/j.1582-4934.2010.01136.x. J Cell Mol Med. 2010. PMID: 20716131 Free PMC article. Review.
-
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.Drug News Perspect. 2004 Jul-Aug;17(6):365-82. doi: 10.1358/dnp.2004.17.6.829028. Drug News Perspect. 2004. PMID: 15334188 Review.
-
The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate.Cell Rep. 2012 Nov 29;2(5):1104-10. doi: 10.1016/j.celrep.2012.09.021. Epub 2012 Oct 25. Cell Rep. 2012. PMID: 23103166 Free PMC article.
-
Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.Annu Rev Physiol. 2017 Feb 10;79:67-91. doi: 10.1146/annurev-physiol-021014-071635. Epub 2016 Oct 21. Annu Rev Physiol. 2017. PMID: 27813829 Free PMC article. Review.
-
Sphingosine 1-phosphate signalling.Development. 2014 Jan;141(1):5-9. doi: 10.1242/dev.094805. Development. 2014. PMID: 24346695 Free PMC article. Review.
Cited by
-
Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling.Differentiation. 2013 Oct;86(3):92-103. doi: 10.1016/j.diff.2013.06.004. Epub 2013 Jul 12. Differentiation. 2013. PMID: 23850217 Free PMC article. Review.
-
A Literature Review of Ozanimod Therapy in Inflammatory Bowel Disease: From Concept to Practical Application.Ther Clin Risk Manag. 2022 Sep 8;18:913-927. doi: 10.2147/TCRM.S336139. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 36106049 Free PMC article. Review.
-
Sphingosine 1-Phosphate Receptor 2 Regulates the Migration, Proliferation, and Differentiation of Mesenchymal Stem Cells.Int J Stem Cell Res Ther. 2015;2(2):014. doi: 10.23937/2469-570x/1410014. Epub 2015 Dec 2. Int J Stem Cell Res Ther. 2015. PMID: 27275017 Free PMC article.
-
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis.Cell Rep. 2022 Dec 6;41(10):111742. doi: 10.1016/j.celrep.2022.111742. Cell Rep. 2022. PMID: 36476873 Free PMC article.
-
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release.Cancer Immunol Immunother. 2010 Apr;59(4):575-86. doi: 10.1007/s00262-009-0775-7. Epub 2009 Oct 13. Cancer Immunol Immunother. 2010. PMID: 19823820 Free PMC article.
References
-
- Dobrowsky RT. Sphingolipid signalling domains floating on rafts or buried in caves? Cell Signal. 2000;12:81–90. - PubMed
-
- Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 2008;9:139–150. - PubMed
-
- Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta. 2006;1758:2016–2026. - PubMed
-
- Bandhuvula P, Saba JD. Sphingosine-1-phosphate lyase in immunity and cancer: silencing the siren. Trends Mol. Med. 2007;13:210–217. - PubMed
-
- Le Stunff H, Peterson C, Liu H, Milstien S, Spiegel S. Sphingosine-1-phosphate and lipid phosphohydrolases. Biochim. Biophys. Acta. 2002;1582:8–17. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources